Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Stopped Recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated.

Conditions

• Inflammation
• Pain
• Cataract

Interventions

• DRUG: Mapracorat
• DRUG: Vehicle

Sponsor

Bausch & Lomb Incorporated